RVL Pharmaceuticals plc Quarterly Lessee, Operating Lease, Liability, to be Paid in USD from Q1 2019 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary
RVL Pharmaceuticals plc quarterly Lessee, Operating Lease, Liability, to be Paid history and growth rate from Q1 2019 to Q4 2022.
  • RVL Pharmaceuticals plc Lessee, Operating Lease, Liability, to be Paid for the quarter ending December 31, 2022 was $538K, a 63.6% decline year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $538K -$941K -63.6% Dec 31, 2022 10-K 2023-03-20
Q4 2021 $1.48M -$717K -32.7% Dec 31, 2021 10-K 2022-03-30
Q4 2020 $2.2M -$3.4M -60.8% Dec 31, 2020 8-K 2021-09-08
Q4 2019 $5.6M Dec 31, 2019 10-K 2020-03-19
Q3 2019 $6.25M Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $7.17M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $7.18M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.